The smart Trick of semaglutude Weeks 13-16 Bundle That No One is Discussing
The trial realized both equally its Major endpoints, with semaglutide 2.4 mg demonstrating statistically considerable and exceptional advancements in liver fibrosis with no worsening of steatohepatitis, along with resolution of steatohepatitis without having worsening of liver fibrosis in those with MASH in comparison to placebo.oneHold all appoint